LINC00205: A Non-Coding RNA Molecule as A Potential Drug Target

Target Name: LINC00205

NCBI ID: G642852

LINC00205

Other Name(s): NCRNA00205 | long intergenic non-protein coding RNA 205 | LVBU | Long intergenic non-protein coding RNA 205

LINC00205: A Non-Coding RNA Molecule as A Potential Drug Target

LINC00205 is a non-coding RNA molecule that has been identified as a potential drug target (or biomarker) for the treatment of various diseases, including cancer. Its unique structure and biology have made it an attractive target for researchers to study, and recent studies have shed light on its role in various biological processes.

LINC00205 is a long non-coding RNA molecule that has a length of approximately 300 amino acid residues. It is expressed in various tissues and organs, including the brain, heart, liver, and muscle. LINC00205 is known for its unique structure, which consists of a series of alternating between G- and A-rich regions.

One of the key features of LINC00205 is its ability to interact with various proteins, including transcription factors. This interaction between LINC00205 and transcription factors allows it to play a role in the regulation of gene expression. Studies have shown that LINC00205 can interact with several transcription factors, including NF-kappa-B, AP-1, and STAT3.

In addition to its interaction with transcription factors, LINC00205 has also been shown to play a role in the regulation of protein translation. This is because LINC00205 contains a protein-coding region that is highly conserved across different species. Studies have shown that LINC00205 can interact with several protein translation factors, including eIF4F, which is involved in the Initiation of protein translation.

The unique structure and biology of LINC00205 have made it an attractive target for researchers to study. Recent studies have shown that LINC00205 can be used as a potential drug target for the treatment of various diseases, including cancer.

One of the main advantages of LINC00205 as a drug target is its small size and ease of manipulation. Because it is a non-coding RNA molecule, researchers have been able to use various techniques to study its biology, including RNA interference and gene editing. This has allowed researchers to quickly and easily identify the effects of LINC00205 on various biological processes.

In addition, LINC00205 has been shown to be involved in multiple biological processes, which makes it an attractive target for the development of new drugs. For example, LINC00205 has been shown to be involved in the regulation of cell growth, differentiation, and survival. This makes it an attractive target for the treatment of cancer, which is a leading cause of death in humans.

LINC00205 has also been shown to have a negative impact on cancer cell proliferation. Studies have shown that LINC00205 can inhibit the growth of cancer cells in both a short-term and long-term setting. This makes it an attractive target for the development of new anti-cancer drugs.

In addition to its potential as a cancer drug, LINC00205 has also been shown to have a positive impact on brain health. Studies have shown that LINC00205 can improve the volume and function of the brain in older adults, which may have potential applications in the treatment of age-related diseases.

Overall, LINC00205 is an attractive drug target due to its unique structure and biology. Its ability to interact with transcription factors and protein translation factors makes it an attractive target for the regulation of gene expression and protein translation. Its negative impact on cancer cell proliferation and positive impact on brain health make it an attractive target for the development of new drugs.

In conclusion, LINC00205 is a non-coding RNA molecule that has a unique structure and biology. Its ability to interact with transcription factors and protein translation factors makes it an attractive target for the regulation of gene expression and protein translation. Its negative impact on cancer cell proliferation and positive impact on brain health make it an attractive target for the development of new drugs. Further studies are needed to fully understand its role in various biological processes and its potential as a drug target.

Protein Name: Long Intergenic Non-protein Coding RNA 205

The "LINC00205 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00205 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets